These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6407502)

  • 21. A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression.
    Roth D; Mattes J; Sheehan KH; Sheehan DV
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):929-39. PubMed ID: 2126144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine.
    Freeman HL; Wakelin JS; Calanca A; Hole G
    Adv Biochem Psychopharmacol; 1982; 32():69-75. PubMed ID: 7046368
    [No Abstract]   [Full Text] [Related]  

  • 23. Flupenthixol and fluvoxamine in mild to moderate depression: a comparison in general practice.
    Hamilton BA; Jones PG; Hoda AN; Keane PM; Majid I; Zaidi SI
    Pharmatherapeutica; 1989; 5(5):292-7. PubMed ID: 2501801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
    Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of major affective disorder with fluvoxamine.
    Lapierre YD; Browne M; Horn E; Oyewumi LK; Sarantidis D; Roberts N; Badoe K; Tessier P
    J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
    Ottevanger EA
    Encephale; 1995; 21(4):317-21. PubMed ID: 7588171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.
    Wakelin JS
    Int Clin Psychopharmacol; 1986 Jul; 1(3):221-30. PubMed ID: 3104446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
    Guelfi JD; Payan C; Fermanian J; Pedarriosse AM; Manfredi R
    Br J Psychiatry; 1992 Apr; 160():519-24. PubMed ID: 1571752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term study of fluvoxamine: a new rapid-acting antidepressant.
    Feldmann HS; Denber HC
    Int Pharmacopsychiatry; 1982; 17(2):114-22. PubMed ID: 6809683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients.
    Gelenberg AJ; Wojcik JD; Newell C; Lamping DL; Spring B
    J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind multicentre trial comparing the efficacy and side-effects of mianserin and chlorimipramine in depressed in- and outpatients.
    Pinder RM; Blum A; Stulemeijer SM; Barres M; Molczadzki M; Rigaud A; Charbaut J; Israel L; Kammerer T
    Int Pharmacopsychiatry; 1980; 15(4):218-27. PubMed ID: 7021447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients.
    Mück-Seler D; Jakovljević M; Deanović Z
    J Affect Disord; 1991 Nov; 23(3):157-64. PubMed ID: 1774431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.
    Feighner JP; Boyer WF; Meredith CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Jul; 4(3):239-44. PubMed ID: 2507630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness.
    Perez A; Ashford JJ
    Curr Med Res Opin; 1990; 12(4):234-41. PubMed ID: 2127561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary-adrenocortical hyperfunction and intolerance to fluvoxamine, a selective serotonin uptake inhibitor.
    Brown WA; Arato M; Shrivastava R
    Am J Psychiatry; 1986 Jan; 143(1):88-90. PubMed ID: 3079969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E; Pelicier Y; Archambault JC; Chabannes JP; Clerc G; Desvilles M; Guibert M; Pagot R; Poisat JL; Thobie Y
    Acta Psychiatr Scand Suppl; 1989; 350():132-4. PubMed ID: 2530766
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
    Kasper S; Voll G; Vieira A; Kick H
    Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Benfield P; Ward A
    Drugs; 1986 Oct; 32(4):313-34. PubMed ID: 3096686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.